fulvestrant
E1394319
UNEXPLORED
Fulvestrant is an estrogen receptor antagonist used as hormone therapy for certain types of advanced or metastatic breast cancer, often in postmenopausal women.
All labels observed (1)
| Label | Occurrences |
|---|---|
| fulvestrant canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T19773031 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: fulvestrant Context triple: [Ibrance, isUsedInCombinationWith, fulvestrant]
-
A.
Lethenteron
Lethenteron is a genus of jawless, eel-like lampreys found primarily in freshwater and coastal regions of the Northern Hemisphere.
-
B.
Vitrakvi
Vitrakvi is a targeted cancer therapy (larotrectinib) used to treat solid tumors that have a specific NTRK gene fusion, regardless of the tumor’s location in the body.
-
C.
Ibrance
Ibrance is a targeted oral cancer medication (palbociclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative advanced or metastatic breast cancer.
-
D.
Verzenio
Verzenio is a prescription cancer medication (abemaciclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative breast cancer.
-
E.
Talycopa
Talycopa is a locality or area within the community of Llansamlet in Swansea, Wales.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: fulvestrant Target entity description: Fulvestrant is an estrogen receptor antagonist used as hormone therapy for certain types of advanced or metastatic breast cancer, often in postmenopausal women.
-
A.
Lethenteron
Lethenteron is a genus of jawless, eel-like lampreys found primarily in freshwater and coastal regions of the Northern Hemisphere.
-
B.
Vitrakvi
Vitrakvi is a targeted cancer therapy (larotrectinib) used to treat solid tumors that have a specific NTRK gene fusion, regardless of the tumor’s location in the body.
-
C.
Ibrance
Ibrance is a targeted oral cancer medication (palbociclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative advanced or metastatic breast cancer.
-
D.
Verzenio
Verzenio is a prescription cancer medication (abemaciclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative breast cancer.
-
E.
Talycopa
Talycopa is a locality or area within the community of Llansamlet in Swansea, Wales.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.